Baxter Healthcare Corporation is recalling over 1 million bags of Levofloxacin Injection in 5% Dextrose due to high out-of-specification results that cause the medication to be superpotent. These injectable antibiotic bags (available in 250 mg, 500 mg, and 750 mg strengths) contain an increased concentration of the drug beyond what is specified on the label. The affected products were manufactured for Claris Lifesciences and distributed nationwide throughout the United States and Puerto Rico.
Using a superpotent drug means a patient may receive a higher dose of the antibiotic than intended. An overdose of levofloxacin can lead to increased side effects or toxicity, potentially impacting patient safety and the effectiveness of the treatment plan.
Healthcare provider consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.